Dynamic MedTech Product Development: Navigating decisions
Navigating MedTech Product Development: Why Flexibility Matters
Assuming that simply following a development process step by step will lead to success in MedTech product development is a mistake. The process gives continuous insights that you cannot predict beforehand. Therefore, achieving success means staying flexible and making informed choices along the way.
Balancing Key Elements
Product development involves balancing multiple factors:
- Performance
- Usability design
- Design for manufacturing
- Clinical and regulatory compliance
- Validation strategies
- Risk management
Moreover, these elements must adapt to project changes and global trends. This ensures products remain state-of-the-art and succeed in the market. From experience, BAAT Medical shares insights where these elements interact and influence each other.
How to Navigate During Development
Usability design is at the heart of the process. It focuses on creating devices that are intuitive, safe, and effective for healthcare providers and patients. However, decisions to improve usability must also consider manufacturability, regulatory requirements, and potential risks.
For example, changing part of a surgical instrument from metal to plastic may improve imaging. Yet, this choice can affect the supplier and require additional biological testing for regulatory approval.
Managing Clinical and Regulatory Complexity
Navigating the clinical and regulatory landscape demands a dynamic strategy. Each design change, intended use modification, or benefit claim revision impacts approval.
For instance, altering intended use could lead to classification under a different 510(k) product code, requiring stricter test criteria. Similarly, revising a benefit claim might extend a clinical study from six months to five years.
Validation Strategies
Validation ensures a product performs as intended in real-world scenarios. However, setting performance claims that are hard to test can make validation commercially unfeasible.
Therefore, validation should be ongoing. Early bench testing, combined with Finite Element Analysis (FEA) and worst-case scenario testing, reduces costs and lead time. Additionally, regulatory strategy must align with validation. Submitting unnecessary tests can trigger avoidable questions. It is better to test for performance but omit non-required tests from submissions.
How BAAT Medical Helps
With 25 years of experience, BAAT Medical integrates usability design, manufacturing efficiency, regulatory compliance, validation strategies, and risk management into daily decisions. Consequently, this agile approach creates innovative, life-enhancing products that improve patient outcomes while maintaining a viable business case.
Together with our customers, BAAT Medical pieces together every part of the puzzle to achieve successful results.